Long-term follow-up of sepsis patients after immune cell therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows patients who were previously enrolled in the ReActIF-ICE study, which investigated the effects of immune cell extracorporeal therapy in addition to standard treatment for severe sepsis. Participants will be monitored for up to five years to gather long-term data on their clinical outcomes, socio-economic impacts, and health-related quality of life. The study aims to provide insights into the lasting effects of sepsis and the potential benefits of the ARTICE treatment compared to standard care alone.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Subject or legal surrogate is willing and able to provide written informed consent and comply with all protocol requirements or the implementation of other established procedures according to the local regulations of the contributing center to include subjects who are unable to provide informed consent.
2. Subject was enrolled in the ReActIF-ICE study and successfully passed the Day 2 re-evaluation of that trial.

Exclusion Criteria:

* none

Where it's running

• Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin
  Magdeburg, Germany Recruiting
• Universitätsmedizin Rostock, Abteilung KAI
  Rostock, Germany Recruiting

Study contacts

• Study coordinator: Erdmann J Zippel, RN
• Email: erdmann.zippel@artcline.de
• Phone: +4915772371146

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Plasma exchange for severely ill kids with sepsis

  This trial tests whether adding therapeutic plasma exchange to standard sepsis care helps critically ill children with severe sepsis or septic shock.

  Recruiting Menoufia University · Shibīn al Kawm, Menoufia Governorate · NCT07706413

• A network to study severe infections in children in China

  This study looks at how common severe infections like pneumonia and sepsis are in children in China to see how they can be better diagnosed and treated.

  Recruiting Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT04955210

• Investigating how transposable elements affect immune aging in sepsis patients

  This study looks at how certain genetic elements might affect the immune system and health outcomes in people with sepsis in the ICU.

  Recruiting University of California, San Francisco · San Francisco, California · NCT06809868

• Identifying biomarkers for diagnosing sepsis in the emergency room

  This study is trying to find out if certain immune responses can help doctors spot sepsis in patients with infections when they arrive at the emergency room.

  Recruiting at 2 sites Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Almere Stad, Flevoland and 2 other locations · NCT06178822

• Reducing unnecessary vancomycin use in children with suspected sepsis

  This study is testing a new approach to see if better guidelines and education can help doctors use less vancomycin in children suspected of having sepsis, which could lower the risk of kidney problems.

  Recruiting at 4 sites Children's Hospital of Philadelphia · Atlanta, Georgia and 3 other locations · NCT05975671

• Early use of norepinephrine for treating severe sepsis

  This study is testing if giving norepinephrine earlier can help people with severe sepsis feel better and live longer compared to a placebo.

  Recruiting Phase 4 Tunis University · Tunis · NCT05836272

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.